The latest gynaecological cancer news
Women warned menopause can mask ovarian cancer
Matter doctors are warning women that the onset of menopause and perimenopause can sometimes mask…
Browsing: Gynaecologic Cancers
FDA approves pembrolizumab with paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal carcinoma
The Food and Drug Administration (FDA) has approved pembrolizumab as well as pembrolizumab and berahyaluronidase…
Overall survival benefit with elenagen plus gemcitabine in platinum-resistant ovarian cancer
Dr. Gabriel Levin, gynaecologic oncologist at the McGill University Health Centre, and Director of Oncology…
Lung cancer drug offers a surprising new treatment against ovarian cancer
A new study published by Mayo Clinic researchers suggests that ovarian cancer cells quickly activate a survival response after PARP inhibitor…
GLP-1 receptor agonists plus progestins and endometrial cancer risk in non-malignant uterine diseases
Endometrial cancer incidence continues to rise in many countries, particularly among women with metabolic dysfunction,…
Opportunistic salpingectomy as a preventive strategy for tubo-ovarian cancer
A new expert consensus published in JAMA supports the use of opportunistic salpingectomy as a…
When ovarian cancer alters the abdominal cavity
Ovarian cancer often goes undetected for a long time. In seven out of 10 patients,…
Cannabis derivatives could provide new ovarian cancer treatments
In the future, scientists could use drugs made from cannabis to target ovarian cancer. A…
New report reveals Australia’s fastest-growing women’s cancer
Uterine cancers are now Australia’s fastest-growing women’s cancer, with incidence doubling over the past 25…
Radiation-induced cellular changes may mimic cancer recurrence in pap smears
A new case report was published in Volume 12 of Oncoscience, titled “Deciphering radiation effects in pap smears:…